World Market Leading Genomics Solution to Excel Next Generation Sequencing (NGS) in Indonesia and the Molecular Biology Industry
World Market Leading Genomics Solution to Excel Next Generation Sequencing (NGS) in Indonesia and the Molecular Biology Industry
World Market Leading Genomics Solution to Excel Next Generation Sequencing (NGS) in Indonesia and the Molecular Biology Industry
Who We Are
Pandu Biosains is an Indonesian-based distributor company for biotechnology and molecular biology research needs that has been supporting genomics programs in Indonesia since 2011. As a leading provider of Next-Generation Sequencing (NGS) and micro array technologies, we strive to support advancing genomic research and applications across the country. With the vision to be the leader in providing molecular biology tools and services, Pandu Biosains is committed to driving innovation and excellence in the field of genomics.
Introduction to NGS and MicroArray
Human
Non-human
NEW SEQUENCER: Illumina MiSeq i100 Series
Sekuenser terbaru dari Illumina yang merupakan sekuenser benchtop PALING SIMPLE dan PALING CEPAT. Dengan keunggulan seperti:
- Tidak perlu thawing reagen
- Dapatkan hasil dalam 1 hari
- Menggunakan teknologi XLEAP-SBS chemistry
Cocok digunakan untuk setiap jenis lab di seluruh dunia!
Instruments
Bench-top Sequencer
Mid-throughput sequencer
high-throughput sequencer
microarray scanner
Meet Pandu Biosains: Indonesia’s Leading Provider of NGS and Microarray Solutions
Our market leading NGS platform Illumina has been contributing to many of world’s genomics research to help improve health.
WHAT’S NEW
Seminar Nasional Tuberkulosis: Memperkuat Pengendalian TB Resistan Obat melalui Targeted Next-Generation Sequencing
Jakarta, 19 Juli 2026 — Perhimpunan Dokter Paru Indonesia (PDPI) bersama PT Pandu Biosains dan Illumina menyelenggarakan seminar tuberkulosis bertajuk “Implementing Targeted Next-Generation Sequencing…
Kapal Ekspedisi Terkena Wabah Hantavirus, Apa yang Perlu Indonesia Antisipasi?
Hantavirus kembali menjadi perhatian dunia setelah laporan outbreak yang dikaitkan dengan kapal ekspedisi internasional MV Hondius pada Mei 2026. Kasus ini menjadi sorotan karena…
Update Kasus Campak di Indonesia Awal 2026: Mengapa Kembali Meningkat?
Campak merupakan salah satu penyakit infeksi yang sebenarnya dapat dicegah melalui vaksinasi. Namun dalam beberapa tahun teraksi, berbagai negara termasuk indonesia kembali…
Our Clients
Keep up with us!
Subscribe to our mailing list and be the first to get updates on upcoming events, our products and quarterly newsletter!